Abstract:
Изобретение относится к различным областям медицины, фармации и фармакологии, химико-фармацевтической, фармацевтической и парафармацевтической промышленности, конкретно касается нового класса средств, обладающих модуляторной активностью с соразмерным влиянием. Изобретение заключается в том, что предлагаемый продукт (RS)-2-(2-оксо-4-фенилпирролидин-1-ил)ацетамид не содержит в своем составе биологически инертных веществ, оказывающих негативное влияние на его впервые выявленные и существенно улучшенные известные свойства и характеристики, открывая при этом ранее не известные основополагающие и наиважнейшие представления о составе, расширяя области его применения с повышением эффективности и безопасности применения, увеличением терапевтической широты, обеспечивает получение продукта и его продукции с выявленными свойствами и характеристиками.
Abstract:
This invention relates to a composition containing (a) a component selected from the group of a mono-or poly- vinyl substituted mono- or polyether, a mono- or poly- vinyl substituted lactam, or a mixture thereof contained in a acidic medium and (b) an aliphatic, primary or secondary mono- or polyamine at a concentration sufficient to adjust the pH of the composition above 7.
Abstract:
Process for the preparation of an N-alkyl lactam with improved colour quality, where 0.01 to 10% by weight of a C 1-10 -alcohol or a compound which releases 0.01 to 10% by weight of a C 1-10 -alcohol is added to the N-alkyl lactam. Mixture comprising at least 99.0% by weight of an N-alkyl lactam and in the range from 100 to 5000 ppm by weight of a C 1-10 -alcohol or of an acetal, aminal or an ortho ester which releases in the range from 100 to 5000 ppm by weight of a C 1-10 -alcohol.
Abstract:
This invention relates to a composition containing (a) a component selected from the group of a mono-or poly- vinyl substituted mono- or polyether, a mono- or poly- vinyl substituted lactam, or a mixture thereof contained in a acidic medium and (b) an aliphatic, primary or secondary mono- or polyamine at a concentration sufficient to adjust the pH of the composition above 7.
Abstract:
The invention relates to various fields of medicine, pharmaceutics and pharmacology and the chemical pharmaceutical, pharmaceutical and parapharmaceutical industry, and specifically concerns a novel class of agents which exhibit modulatory activity with a commensurate effect. The essence of the invention is that the proposed (RS)-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide product does not contain biologically inert substances which exert a negative effect on its newly discovered or significantly improved known properties and characteristics, giving rise to hitherto unknown fundamental and highly important ideas about the compound, expanding the scope of use thereof with an increase in the effectiveness and safety of use and an increase in the therapeutic index, and making it possible to produce the product and related products with the newly found properties and characteristics.
Abstract:
The invention relates to a method for storing and transporting N-vinyl- epsilon -caprolactam, which is characterized by maintaining the N-vinyl- epsilon -caprolactam in the liquid phase.
Abstract:
The invention relates to a method for storing and transporting N-vinyl- epsilon -caprolactam, which is characterized by maintaining the N-vinyl- epsilon -caprolactam in the liquid phase.
Abstract:
Process for the preparation of an N-alkyl lactam with improved colour quality, where 0.01 to 10% by weight of a C1-10-alcohol or a compound which releases 0.01 to 10% by weight of a C1-10-alcohol is added to the N-alkyl lactam. Mixture comprising at least 99.0% by weight of an N-alkyl lactam and in the range from 100 to 5000 ppm by weight of a C1-10-alcohol or of an acetal, aminal or an ortho ester which releases in the range from 100 to 5000 ppm by weight of a C1-10-alcohol.